Regenerex Pharma (RGPX) Short term Debt (2017 - 2023)

Regenerex Pharma (RGPX) has 7 years of Short term Debt data on file, last reported at $131887.0 in Q1 2023.

• Short term Debt for Q1 2023 came in at $131887.0, changed 0.15% year-over-year; the trailing twelve-month figure through Mar 2023 was $131887.0 (changed 0.15% YoY), and the FY2023 annual result was $131887.0, changed 0.15% from the prior year.
• Short term Debt held at $131887.0 in Q1 2023 per RGPX's latest filing, from $131887.0 in the prior quarter.
• Over five years, Short term Debt peaked at $139287.0 in Q3 2022 and troughed at $100.0 in Q4 2021.
• A 5-year average of $123534.6 and a median of $130992.0 in 2019 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2020 and 2022: Short term Debt changed 0.0% in 2020, then jumped 131787.0% in 2022.
• A 5-year view of Short term Debt shows it stood at $130992.0 in 2019, then changed by 0.0% to $130992.0 in 2020, then plunged by 99.92% to $100.0 in 2021, then jumped by 131787.0% to $131887.0 in 2022, then changed by 0.0% to $131887.0 in 2023.
• Business Quant data shows RGPX's Short term Debt at $131887.0 in Q1 2023, $131887.0 in Q4 2022, and $139287.0 in Q3 2022.